| 000 | 01548 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517092806.0 | ||
| 264 | 0 | _c20180105 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.8882 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaporte, Aimée N | |
| 245 | 0 | 0 |
_aIdentification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay. _h[electronic resource] |
| 260 |
_bOncotarget _cJun 2016 |
||
| 300 |
_a34384-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzodioxoles _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCo-Repressor Proteins |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHigh-Throughput Screening Assays |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 |
_aOncogene Proteins, Fusion _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProtein Interaction Maps |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aRepressor Proteins _xmetabolism |
| 650 | 0 | 4 |
_aSarcoma, Synovial _xdrug therapy |
| 700 | 1 | _aJi, Jennifer X | |
| 700 | 1 | _aMa, Limin | |
| 700 | 1 | _aNielsen, Torsten O | |
| 700 | 1 | _aBrodin, Bertha A | |
| 773 | 0 |
_tOncotarget _gvol. 7 _gno. 23 _gp. 34384-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.8882 _zAvailable from publisher's website |
| 999 |
_c25964713 _d25964713 |
||